Developing an Erythrocyte-MHC-I Conjugate for Cancer Treatment

Developing an Erythrocyte-MHC-I Conjugate for Cancer Treatment

Developing a Novel Erythrocyte-MHC-I Conjugate for Cancer Treatment: A Revolutionary Immunotherapy Research Background: Traditional Roles and Newly Discovered Potential Erythrocytes, or red blood cells, are the most abundant cells in the human body, comprising approximately 70% of total cell count in adults. Traditionally recognized for their role ...